Edgewood Management’s Armata Pharmaceuticals ARMP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $190K | Hold |
100,000
| – | – | ﹤0.01% | 79 |
|
2025
Q1 | $146K | Hold |
100,000
| – | – | ﹤0.01% | 80 |
|
2024
Q4 | $185K | Hold |
100,000
| – | – | ﹤0.01% | 80 |
|
2024
Q3 | $237K | Hold |
100,000
| – | – | ﹤0.01% | 72 |
|
2024
Q2 | $275K | Hold |
100,000
| – | – | ﹤0.01% | 71 |
|
2024
Q1 | $418K | Hold |
100,000
| – | – | ﹤0.01% | 68 |
|
2023
Q4 | $324K | Hold |
100,000
| – | – | ﹤0.01% | 68 |
|
2023
Q3 | $300K | Hold |
100,000
| – | – | ﹤0.01% | 70 |
|
2023
Q2 | $114K | Hold |
100,000
| – | – | ﹤0.01% | 80 |
|
2023
Q1 | $167K | Hold |
100,000
| – | – | ﹤0.01% | 80 |
|
2022
Q4 | $124K | Hold |
100,000
| – | – | ﹤0.01% | 81 |
|
2022
Q3 | $422K | Hold |
100,000
| – | – | ﹤0.01% | 69 |
|
2022
Q2 | $389K | Hold |
100,000
| – | – | ﹤0.01% | 68 |
|
2022
Q1 | $489K | Hold |
100,000
| – | – | ﹤0.01% | 70 |
|
2021
Q4 | $548K | Buy |
100,000
+50,000
| +100% | +$274K | ﹤0.01% | 70 |
|
2021
Q3 | $181K | Hold |
50,000
| – | – | ﹤0.01% | 80 |
|
2021
Q2 | $198K | Hold |
50,000
| – | – | ﹤0.01% | 79 |
|
2021
Q1 | $239K | Buy |
50,000
+10,000
| +25% | +$47.8K | ﹤0.01% | 78 |
|
2020
Q4 | $119K | Hold |
40,000
| – | – | ﹤0.01% | 79 |
|
2020
Q3 | $128K | Hold |
40,000
| – | – | ﹤0.01% | 77 |
|
2020
Q2 | $157K | Hold |
40,000
| – | – | ﹤0.01% | 74 |
|
2020
Q1 | $124K | Buy |
40,000
+20,000
| +100% | +$62K | ﹤0.01% | 76 |
|
2019
Q4 | $65K | Buy |
+20,000
| New | +$65K | ﹤0.01% | 84 |
|